Variants resulting in impaired BCR signaling are thought to contribute to autoimmunity in a mechanism analogous to that noted in the monogenic immunodeficiencies discussed above, in which inadequate pre‐BCR signaling leads to failure in reaching the threshold for clonal deletion or BCR rearrangement 12, 33. This evidence concerns the gene BCR and Immunodeficiency.